Evaluation of the effectiveness of the abatacept (ORENCIA®) intravenous and subcutaneous formulation Patient Alert Cards in patients with rheumatoid arthritis in a sample of European Economic Area countries First published 30/06/2015 Last updated 02/07/2024 EU PAS number:EUPAS10122 Study Finalised